Funding for this research was provided by:
National Comprehensive Cancer Network (Young investigators award)
American Cancer Society (Institutional grant)
National Institutes of Health (K23 CA204726, NIH R01CA227481)
Article History
First Online: 23 May 2020
Compliance with Ethical Standards
:
: This work was funded by a National Comprehensive Cancer Network (NCCN) Young Investigators Award (DBJ), an American Cancer Society institutional research Grant (DBJ), and the National Institutes of Health, Grant numbers: K23 CA204726 (DBJ), NIH R01CA227481 (DBJ).
: Douglas B. Johnson serves on advisory boards for Array Biopharma, BMS, Incyte, Jansen, Merck, and Novartis; receives research funding from BMS and Incyte; and receives travel support from Genentech. J. Randall Patrinely Jr and Anna K. Dewan have no conflicts of interest that might be relevant to the contents of this manuscript.
Free to read: This content has been made available to all.